Badgley Phelps Wealth Managers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Badgley Phelps Wealth Managers's BMY Position: Q1 2026 in Review
Badgley Phelps Wealth Managers increased its Bristol-Myers Squibb (BMY) stake by 13% in Q1 2026, buying an estimated $187K and bringing the position to 27,117 shares worth $1.64M. The position accounts for 0.03% of the portfolio, ranked #175.
Badgley Phelps Wealth Managers first reported a position in BMY in Q3 2021 and has held it in 19 quarters since. The position peaked at $19.7M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Badgley Phelps Wealth Managers held 27,117 shares of Bristol-Myers Squibb worth $1.64M as of Q1 2026.
- Badgley Phelps Wealth Managers bought 3,200 Bristol-Myers Squibb shares in Q1 2026, an estimated $187K.
- Bristol-Myers Squibb made up 0.03% of Badgley Phelps Wealth Managers's portfolio in Q1 2026, its #175 holding.
- Badgley Phelps Wealth Managers first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 19 quarters since.
- Badgley Phelps Wealth Managers's Bristol-Myers Squibb position peaked at $19.7M in Q2 2022.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Badgley Phelps Wealth Managers's 13F filing for Q1 2026, filed 15 Apr 2026.